δ-Opioid receptor agonist SNC80 induces central antinociception mediated by Ca2+-activated Cl- channels

Journal of Pharmacy and Pharmacology

Volumn 64, Issue 8, 2012, Pages 1084-1089

  Pacheco, Daniela Da Fonseca ^a   Pacheco, Cinthia Mara Da Fonseca ^b   Duarte, Igor Dimitri Gama ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b CENTRO UNIVERSITÁRIO NEWTON PAIVA   (Brazil)

Author keywords

Bremazocine; CaCC; DAMGO; Niflumic acid; SNC80

Indexed keywords

4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 METHOXYBENZYL] N,N DIETHYLBENZAMIDE; BREMAZOCINE; CALCIUM ION; CHLORIDE CHANNEL; DELTA OPIATE RECEPTOR; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; KAPPA OPIATE RECEPTOR; MU OPIATE RECEPTOR; NIFLUMIC ACID;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG MECHANISM; MALE; MOUSE; NONHUMAN; PAIN THRESHOLD; TAIL FLICK TEST; THERMAL STIMULATION;

ANALGESICS, OPIOID; ANIMALS; BENZAMIDES; BENZOMORPHANS; CALCIUM; CATIONS; CHLORIDE CHANNELS; ENKEPHALINS; HOT TEMPERATURE; MALE; MICE; MICE, INBRED STRAINS; NIFLUMIC ACID; PAIN; PAIN THRESHOLD; PIPERAZINES; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU;

EID: 84863727642     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/j.2042-7158.2012.01472.x     Document Type: Article

References (34)

1. Bhargava HN,. Diversity of agents that modify opioid tolerance. Physical dependence, abstinence syndrome and self administrative behavior. Pharmacol Rev 1994; 46: 293-323.
2. Singh VK, et al,. Molecular biology of opioid receptors: recent advances. Neuroimmunomodulation 1997; 4: 285-297. (Pubitemid 28231592)
3. Childers SR,. Opioid receptor-coupled second messengers. Life Sci 1991; 48: 1991-2003.
4. Gilman AG,. G-protein: transducers of receptor generated signals. Annu Rev Biochem 1987; 56: 615-649.
5. Pert CB, et al,. Opiate receptor: autoradiographic localization in rat brain. Proc Natl Acad Sci USA 1976; 73: 3729-3733.
6. Atweh SF, Kuhar MJ,. Autoradiographic localization of opiate receptors in rat brain. Brain Res 1977; 129: 1-12. (Pubitemid 8123246)
7. Mansour A, et al,. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci 1995; 18: 22-29.
8. Hartzell C, et al,. Calcium-activated chloride channels. Annu Rev Physiol 2005; 67: 719-758. (Pubitemid 40404508)
9. - channels-homing in on an elusive channel species. Prog Neurobiol 2000; 60: 247-289.
10. 2+ release. Naunyn Schmiedebergs Arch Pharmacol 1999; 359: 81-91. (Pubitemid 29142877)
11. Verkman AS, Galietta LJ,. Chloride channels as drug targets. Nat Rev Drug Discov 2009; 8: 153-171.
12. Kuruma A, Hartzell HC,. Bimodal control of a Ca(2+)-activated Cl(-) channel by different Ca(2+) signals. J Gen Physiol 2000; 115: 59-80. (Pubitemid 30043668)
13. (+ current activated δ-opioid receptor-mediated antinociception in the mouse spinal cord. Neurosci Lett 2000; 295: 113-115.
14. D'amour FE, Smith DL,. A method for determining loss of pain sensation. J Pharmacol Exp Ther 1941; 72: 74-79.
15. Haley TJ, McCormick WG,. Pharmacological effects produced by intracerebroventricular injection of drugs in the conscious mouse. Br J Pharmacol Chemother 1957; 12: 12-15.
16. Mayer ML,. A calcium-activated chloride current generates the after-depolarization of rat sensory neurones in culture. J Physiol 1985; 364: 217-239. (Pubitemid 15067209)
17. Kirkup AJ, et al,. Investigation of the effects of 5-nitro-2- (phenylpropylamino)-benzoic acid (NPPB) on membrane currents in rat portal vein. Br J Pharmacol 1996; 117: 175-183.
18. - channels in xenopus oocytes. Mol Pharmacol 1990; 37: 720-724. (Pubitemid 20171508)
19. Harks EG, et al,. Fenamates: a novel class of reversible gap junction blockers. J Pharmacol Exp Ther 2001; 298: 1033-1041. (Pubitemid 32761919)
20. + channels. Implications for the study of the I(to2) current. Circ Res 1997; 81: 711-718.
21. Xu WX, et al,. Volume-sensitive chloride current activated by hyposmotic swelling in antral gastric myocytes of the guinea-pig. Pflugers Arch 1997; 435: 9-19. (Pubitemid 28068734)
22. - channel blockers inhibits secretion from rat mucosal-type mast cells. Mol Pharmacol 1995; 47: 1014-1020.
23. Jentsch TJ, et al,. Molecular structure and physiological function of chloride channels. Physiol Rev 2002; 82: 503-568. (Pubitemid 34654460)
24. Narita M, et al,. Role of the phosphatidylinositol-specific phospholipase C pathway in δ-opioid receptor-mediated antinociception in the mouse spinal cord. Neurosc 2000; 99: 327-331. (Pubitemid 30628420)
25. Ferreira SH, et al,. The molecular mechanism of action of peripheral morphine analgesia: stimulation of the cGMP system via nitric oxide release. Eur J Pharmacol 1991; 201: 121-122.
26. 2 receptors and activation of the L-arginine/nitric oxide/cyclic GMP pathway. Life Sci 2005; 78: 54-60. (Pubitemid 41527231)
27. + channels. Eur J Pharmacol 2005; 512: 23-28. (Pubitemid 40462359)
28. + channels. Br J Pharmacol 2000; 129: 110-114. (Pubitemid 30072676)
29. Machelska H, et al,. Inhibition of nitric oxide synthase enhances antinociception mediated by mu, delta and kappa opioid receptors in acute and prolonged pain in the rat spinal cord. J Pharmacol Exp Ther 1997; 282: 977-984.
30. Vivancos GG, et al,. Opposite nociceptive effects of the arginine/NO/cGMP pathway stimulation in dermal and subcutaneous tissues. Br J Pharmacol 2003; 138: 1351-1357. (Pubitemid 36543133)
31. 2+ and NO. Am J Physiol 1999; 277: 1732-1744.
32. Matchkov VV, et al,. A cyclic-dependent calcium-activated chloride current in smooth-muscle cells from rat mesenteric resistance arteries. J Gen Physiol 2004; 123: 121-134. (Pubitemid 38176605)
33. 2+ from different sources in mouse sympathetic neurones. J Physiol 2000; 527: 249-264.
34. - channels. J Clin Invest 2010; 120: 1240-1252.